Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia
Sign Up to like & getrecommendations! Published in 2024 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2024.2343885
Abstract: ABSTRACT Background Studies on dasatinib-based low-intensity induction regimens and post-remission strategies are limited in China. Therefore, we conducted a single-center phase 2 trial in newly diagnosed adult patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia… read more here.
Keywords: intensity; philadelphia chromosome; low intensity; chromosome positive ... See more keywords
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
Sign Up to like & getrecommendations! Published in 2024 at "Blood Advances"
DOI: 10.1182/bloodadvances.2024014405
Abstract: Key Points • Venetoclax plus low-intensity chemotherapy can be safely administered in ALL.• Venetoclax plus low-intensity chemotherapy is a promising therapy in older patients with newly diagnosed, high-risk ALL. read more here.
Keywords: low intensity; plus low; venetoclax plus; intensity chemotherapy ... See more keywords